Home / Audit and Guideline / USFDA WARNING LETTER 2016 (Finished Pharmaceuticals)

USFDA WARNING LETTER 2016 (Finished Pharmaceuticals)

Noven Pharmaceuticals, Inc. 8/5/16

Huzhou Aupower Sanitary Commodity 8/10/16

Frontida BioPharm Inc 8/15/16

College Pharmacy Incorporated 8/15/16

Ajes Pharmaceuticals LLC 9/9/16

Mappel Industria de Embalagens S.A. 9/12/16

Cheng Fong Chemical Co., Ltd. 9/15/16

Yangzhou Hengyuan Daily Chemical Plastic Co Ltd 9/26/16

Laboratoire Sintyl S.A. 9/29/16

Delarange Cosmetics BV 9/29/16

Austin Biotechnology Inc. 6/2/16

S.R. Burzynski Manufacturing Facility 6/13/16

Sri Krishna Pharmaceuticals Ltd. – Unit II 4/1/16

Emcure Pharmaceuticals Limited 3/3/16

Ipca Laboratories Limited 1/29/16

Millers of Wyckoff, Inc. 6/7/16

 

About Pharmaceutical Guidanace

Mr. Shiv Kumar is the Author and founder of pharmaceutical guidance, he is a pharmaceutical Professional from India having more than 14 years of rich experience in pharmaceutical field. During his career, he work in quality assurance department with multinational company’s i.e Zydus Cadila Ltd, Unichem Laboratories Ltd, Indoco remedies Ltd, Panacea Biotec Ltd, Nectar life Science Ltd. During his experience, he face may regulatory Audit i.e. USFDA, MHRA, ANVISA, MCC, TGA, EU –GMP, WHO –Geneva, ISO 9001-2008 and many ROW Regularities Audit i.e.Uganda,Kenya, Tanzania, Zimbabwe. He is currently leading a regulatory pharmaceutical company as a head Quality. You can join him by Email, Facebook, Google+, Twitter and YouTube

Check Also

Buildings and Facilities in pharma industry as per USFDA

Buildings and Facilities in pharma industry Design and construction features in pharma industry  (a) Any building …